• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53突变与原发性输卵管腺癌的高S期比例相关。

p53 mutation is associated with high S-phase fraction in primary fallopian tube adenocarcinoma.

作者信息

Runnebaum I B, Köhler T, Stickeler E, Kieback H R, Kreienberg R

机构信息

Department of Obstetrics and Gynaecology, University of Ulm, Germany.

出版信息

Br J Cancer. 1996 Oct;74(8):1157-60. doi: 10.1038/bjc.1996.510.

DOI:10.1038/bjc.1996.510
PMID:8883398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2075926/
Abstract

Fallopian tube carcinoma (FTC) is a rare but lethal gynaecological malignancy. Four out of seven FTCs were identified with three point missense mutations, one single base deletion and one silent point mutation in the p53 gene. Genital-type HPV sequences were not detected. The S-phase fraction of tumours with mutant and wild-type p53 was 25.74% (median) and 12.55% (median) respectively.

摘要

输卵管癌(FTC)是一种罕见但致命的妇科恶性肿瘤。在七个FTC病例中,有四个被发现p53基因存在三个点错义突变、一个单碱基缺失和一个沉默点突变。未检测到生殖器型人乳头瘤病毒(HPV)序列。p53基因发生突变和野生型的肿瘤的S期分数分别为25.74%(中位数)和12.55%(中位数)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/479d/2075926/8891c409bbef/brjcancer00024-0007-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/479d/2075926/8891c409bbef/brjcancer00024-0007-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/479d/2075926/8891c409bbef/brjcancer00024-0007-a.jpg

相似文献

1
p53 mutation is associated with high S-phase fraction in primary fallopian tube adenocarcinoma.p53突变与原发性输卵管腺癌的高S期比例相关。
Br J Cancer. 1996 Oct;74(8):1157-60. doi: 10.1038/bjc.1996.510.
2
Overexpression of p53 and HER-2/neu and c-myc in primary fallopian tube carcinoma.p53、HER-2/neu和c-myc在原发性输卵管癌中的过表达。
Gynecol Obstet Invest. 2000;49(1):47-51. doi: 10.1159/000010212.
3
p53 mutant His175 identified in a newly established fallopian tube carcinoma cell line secreting interleukin 6.在一种新建立的分泌白细胞介素6的输卵管癌细胞系中鉴定出p53突变体His175。
FEBS Lett. 1994 Oct 10;353(1):29-32. doi: 10.1016/0014-5793(94)00953-8.
4
Microinvasive fimbrial fallopian tube carcinoma in a BRCA-2 mutation carrier.
Int J Gynaecol Obstet. 2008 May;101(2):200. doi: 10.1016/j.ijgo.2007.11.017. Epub 2008 Jan 22.
5
HER-2/neu and p27Kip1 in progression of Fallopian tube carcinoma: an immunohistochemical and array comparative genomic hybridization study.HER-2/neu和p27Kip1在输卵管癌进展中的作用:一项免疫组织化学和阵列比较基因组杂交研究
Histopathology. 2007 Nov;51(5):666-73. doi: 10.1111/j.1365-2559.2007.02850.x.
6
[Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].[PAX8、PAX2、p53和RAS在卵巢及输卵管中的表达及其对卵巢高级别浆液性癌起源的意义]
Zhonghua Fu Chan Ke Za Zhi. 2017 Oct 25;52(10):687-696. doi: 10.3760/cma.j.issn.0529-567X.2017.10.008.
7
Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.人乳头瘤病毒感染阳性和阴性的原发性宫颈癌中p53基因的改变
Cancer Res. 1992 Oct 1;52(19):5323-8.
8
Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes.p53基因突变在临床晚期及具有侵袭性组织学表型的子宫癌中频繁发生。
Jpn J Cancer Res. 1992 Nov;83(11):1184-91. doi: 10.1111/j.1349-7006.1992.tb02743.x.
9
Promoter hypermethylation patterns in fallopian tube epithelium of BRCA1 and BRCA2 germ line mutation carriers.BRCA1 和 BRCA2 种系突变携带者的输卵管上皮启动子高甲基化模式。
Endocr Relat Cancer. 2012 Feb 13;19(1):69-81. doi: 10.1530/ERC-11-0338. Print 2012 Feb.
10
A candidate precursor to serous carcinoma that originates in the distal fallopian tube.一种起源于输卵管远端的浆液性癌候选前体。
J Pathol. 2007 Jan;211(1):26-35. doi: 10.1002/path.2091.

引用本文的文献

1
Human Papillomaviruses and Malignant Neoplasms of the Female Upper Reproductive Tract: A Comprehensive Review of the Literature.人乳头瘤病毒与女性上生殖道恶性肿瘤:文献综述
Cancers (Basel). 2025 Jun 15;17(12):1995. doi: 10.3390/cancers17121995.
2
Primary fallopian tube cancer: a review of the literature.
Med Oncol. 1998 Apr;15(1):6-14. doi: 10.1007/BF02787338.

本文引用的文献

1
Retrovirally mediated wild-type p53 restores S-phase modulation without inducing WAF1 mRNA in breast carcinoma cells containing mutant p53.逆转录病毒介导的野生型p53可在含有突变型p53的乳腺癌细胞中恢复S期调节,而不诱导WAF1 mRNA。
J Cell Biochem. 1995 Dec;59(4):537-44. doi: 10.1002/jcb.240590413.
2
Subcellular localization of accumulated p53 in ovarian cancer cells.
Gynecol Oncol. 1996 May;61(2):266-71. doi: 10.1006/gyno.1996.0137.
3
p53 gene mutations and protein accumulation in human ovarian cancer.人类卵巢癌中的p53基因突变与蛋白积累
Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):4961-5. doi: 10.1073/pnas.90.11.4961.
4
p53 mutation is a common genetic event in ovarian carcinoma.p53基因变异是卵巢癌中常见的基因事件。
Cancer Res. 1993 May 1;53(9):2128-32.
5
p53-mediated cell death: relationship to cell cycle control.p53介导的细胞死亡:与细胞周期调控的关系
Mol Cell Biol. 1993 Mar;13(3):1415-23. doi: 10.1128/mcb.13.3.1415-1423.1993.
6
Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis.腺病毒5 E1A可诱导p53肿瘤抑制因子的稳定,并伴随细胞凋亡。
Genes Dev. 1993 Apr;7(4):535-45. doi: 10.1101/gad.7.4.535.
7
Primary carcinoma of the fallopian tube--a retrospective analysis of 115 patients. Austrian Cooperative Study Group for Fallopian Tube Carcinoma.原发性输卵管癌——115例患者的回顾性分析。奥地利输卵管癌合作研究组
Br J Cancer. 1993 Sep;68(3):605-9. doi: 10.1038/bjc.1993.394.
8
WAF1, a potential mediator of p53 tumor suppression.WAF1,一种p53肿瘤抑制的潜在介导因子。
Cell. 1993 Nov 19;75(4):817-25. doi: 10.1016/0092-8674(93)90500-p.
9
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.p21 Cdk相互作用蛋白Cip1是G1期细胞周期蛋白依赖性激酶的有效抑制剂。
Cell. 1993 Nov 19;75(4):805-16. doi: 10.1016/0092-8674(93)90499-g.
10
Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.肿瘤抑制因子p53在体外和体内都是bcl-2和bax基因表达的调节因子。
Oncogene. 1994 Jun;9(6):1799-805.